Metabolic Effects of Bariatric Surgery

Bariatric Procedures & Metabolic Goals - Gut Reaction!

• Alters gut anatomy for weight loss & metabolic improvement.
• Key Procedures:
  • Roux-en-Y Gastric Bypass (RYGB): Gold standard; restrictive & malabsorptive.
  • Sleeve Gastrectomy (SG): Most common; restrictive.
• Metabolic Goals:
  • Weight loss >25% total body weight.
  • T2DM remission/improvement.
  • Enhanced insulin sensitivity.
  • Favorable gut hormone changes: ↑ GLP-1, ↑ PYY, ↓ Ghrelin (post-SG).

  ⭐ RYGB shows rapid T2DM improvement, often pre-weight loss, due to incretin effect & gut hormone modulation. oka

Key Hormonal Shifts Post-Surgery - Gut Feeling Fiesta

Bariatric procedures trigger major gut hormone shifts: 📌 Mnemonic: Hungry Ghrelin ↓, Full PYY & GLP-1 ↑.

• GLP-1 & PYY: ↑↑ (Hindgut effect: rapid distal nutrient delivery).
  • Effects: ↑ Insulin, ↓ Glucagon, ↑ Satiety, ↓ Gastric emptying (GLP-1); ↓ Appetite, ↓ Motility (PYY).
• Ghrelin ("Hunger Hormone"): ↓↓ (esp. Sleeve via fundus removal).
  • Effect: ↓ Appetite.
• Leptin: ↓ (due to ↓ fat mass). Sensitivity ↑.
• Theories Explaining ↑GLP-1/PYY & Other Benefits:
  • Hindgut: Rapid distal nutrient delivery → ↑GLP-1/PYY.
  • Foregut: Proximal gut (duodenum) bypass → ↓putative anti-incretins.

⭐ Post-RYGB/Sleeve, marked ↑ in GLP-1 & PYY are crucial for T2DM remission.

T2DM Remission & Glucose Control - Sugar Surrender

Bariatric surgery significantly improves Type 2 Diabetes Mellitus (T2DM), often leading to remission.

• Primary Mechanisms:
  • Altered gut hormone secretion: ↑ Glucagon-Like Peptide-1 (GLP-1), ↑ Peptide YY (PYY).
  • ↓ Ghrelin levels (especially post-SG/RYGB).
  • Enhanced insulin sensitivity in liver and peripheral tissues.
  • Improved β-cell function and mass preservation.
• Remission Rates (approximate):
  • Roux-en-Y Gastric Bypass (RYGB): 60-80%.
  • Sleeve Gastrectomy (SG): 50-70%.
  • Laparoscopic Adjustable Gastric Banding (LAGB): 20-50%.
• Positive Predictors for Remission:
  • Shorter T2DM duration (<5 years).
  • Lower pre-operative HbA1c.
  • Non-insulin dependent T2DM pre-op.

⭐ Rapid improvement in glycemic control, often within days of RYGB, can occur before significant weight loss, attributed to acute hormonal changes (incretin effect).

Lipid Metabolism & Liver Health - Fat Farewell

• Dyslipidemia Correction:
  • Significant ↓ in Triglycerides (TGs) by ~50%.
  • ↑ HDL cholesterol by ~10-20%.
  • LDL cholesterol: often ↓; shift to larger, less atherogenic particles.
• NAFLD/NASH Resolution:
  • Dramatic improvement in Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
  • ↓ Hepatic steatosis, inflammation, and fibrosis.
  • Normalization of liver enzymes (ALT, AST).

⭐ Bariatric surgery can lead to NASH resolution in up to 85% of patients and fibrosis regression in ~30-50%.

Micronutrients & Bone Integrity - Vitamin Vigilance

• Key Deficiencies:
  • Iron: Most common (RYGB/BPD-DS): malabsorption, ↓acid. Screen regularly.
  • Vit B12: ↓IF (RYGB/SG), ↓acid. Neuropathy risk.
  • Vit D & Ca: Malabsorption (RYGB/BPD-DS) → 2° HPT, ↑bone loss, osteoporosis.
  • Thiamine (B1): Deficiency (vomiting) → Wernicke's (neuro emergency).
  • Folate, Cu, Zn also monitored.
• Bone Integrity:
  • ↑ Long-term fracture risk.
  • Mechanisms: Malabsorption, hormonal shifts (↑PTH), ↓load.

⭐ Iron deficiency: most common post-bariatric surgery, screen routinely.

• Management: Lifelong supplementation & monitoring crucial for prevention.

High‑Yield Points - ⚡ Biggest Takeaways

• RYGB & Sleeve Gastrectomy show highest T2DM remission rates, often independent of weight loss.
• Key hormonal changes: ↑ GLP-1 & PYY (improve glucose control, satiety); ↓ Ghrelin (reduces hunger, mainly post-sleeve).
• Significant improvement in dyslipidemia (↓ Triglycerides, ↓ LDL, ↑ HDL) & hypertension.
• Alterations in gut microbiota & bile acid metabolism contribute to metabolic benefits.
• Nutrient malabsorption (iron, B12, Ca, Vit D) is a crucial long-term metabolic consequence requiring monitoring.